Jacobus Pharmaceutical Company Inc. Issues Voluntary Worldwide Recall of Ruzurgi ® (amifampridine) 10 mg Tablets Due to Yeast, Mold, and Bacterial Contamination

Plainsboro, New Jersey, Jacobus Pharmaceutical Company Inc. is voluntarily recalling 3 lots of Ruzurgi ® (amifampridine) 10 mg tablets to the consumer level. The products have been found to be contaminated with yeast, mold, and aerobic bacteria based on laboratory test results. Oral products heavily
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news